Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-03-03 @ 4:44 PM
Study NCT ID:
NCT03609359
Status:
COMPLETED
Last Update Posted:
2025-04-16
First Post:
2018-07-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenvatinib and Pembrolizumab Simultaneous Combination Study
Sponsor:
National Cancer Center Hospital East
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-23
First Submit QC Date:
None
Study First Post Date:
2018-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-04-12
Results First Submit QC Date:
None
Results First Post Date:
2025-04-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-27
Last Update Post Date:
2025-04-16
Last Update Post Date Type:
ACTUAL